MICB, PSMB2, PSMB8 and PSME2 showed consistently low level of expression in melioidosis cohort irrespective of other factors like comorbidities (risk factors), duration of clinical symptoms and antibiotic treatment, compared to other sepsis controls (Tables 2–5, Figs 1–3). This evidence concerns the gene PSMB8 and Sepsis.